Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon-PR Newswire APAC

Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon-PR Newswire APAC

NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the FDA for its "Breakthrough Program". SELUTION...

Read more: Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon-...

More Articles …

  1. Newgen Recognized for the First Time in Gartner Magic Quadrant for Enterprise Low-Code Application Platforms-PR Newswire APAC
  2. The Ninth Open Innovations Forum To Be Held Online-PR Newswire APAC
  3. Saudi Arabia to host the 1st International Conference on Giftedness and Creativity in November-PR Newswire APAC
  4. Vection Integrates With DELL Precision HW To Power Global VR Solution-PR Newswire APAC
  5. Competentia announces acquisition of Dare, significantly expanding footprint in the Asia Pacific region-PR Newswire APAC
  6. UnionPay International Introduces QR Code Payment Solution to Retailers in Australia and New Zealand-PR Newswire APAC
  7. Financial Services Brands Struggle To Differentiate CX Quality-PR Newswire APAC
  8. Shine launches Quick Start for Adobe Experience Manager (AEM) OpenCloud on Amazon Web Services (AWS)-PR Newswire APAC
  9. Warburg Pincus to invest $95MN (INR 700 CR) in Home First
  10. Biom'up Australian Market Growth Gathers Pace-PR Newswire APAC